Ruth Clegg

Private full-body health checks are growing rapidly, with companies such as Neko Health charging hundreds of pounds for scans designed to detect disease before symptoms appear. Supporters argue that preventive screening could transform primary care, citing cases such as Mehvish’s early diagnosis of latent autoimmune diabetes. However, doctors and NHS bodies warn that the scans lack convincing evidence of improved outcomes, can miss serious conditions—as in Annabel Mason-Thompson’s case—and may lead to false alarms, anxiety, unnecessary follow-up tests and extra pressure on the NHS. The experience of the reporter, whose flagged skin and heart findings ultimately required no treatment, illustrates both the reassurance and uncertainty these services can create.

Testosterone prescriptions have risen sharply in the United Kingdom as reported sexual activity and libido decline, but experts say the causes include stress, depression, loneliness, digital lifestyles, relationships and health conditions—not testosterone alone. Some men and women describe testosterone replacement therapy as restoring energy, desire and relationship quality, while others report excessive libido, anger and other side effects. NHS guidance supports limited use, particularly for postmenopausal women with hypoactive sexual desire disorder, but diagnostic thresholds and access vary, and women often receive treatment off-label. Clinicians warn that private clinics and wellness marketers may be overselling TRT for profit, with evidence supporting its effectiveness only for a relatively narrow group. The treatment can help selected patients but is not a universal or “silver bullet” solution.

Daniel Murphy developed insomnia, mania and severe psychosis after taking Paradigm Peptides products that he believed were SARMs but had been adulterated with testosterone. The company’s owner, Matthew Kawa, and his sister Jennifer Stechkober admitted selling unapproved drugs, falsifying certificates and misleading customers about manufacturing, purity and testing; they received prison sentences. An FDA investigation found testosterone in all tested SARM products, while experts warned that the global, lightly regulated peptide and SARM market leaves consumers vulnerable to undisclosed ingredients and serious psychiatric, cardiac and other health effects. Murphy says he recovered after stopping the supplements and is seeking compensation alongside other affected consumers.